Managing insomnia in the primary care setting: Raising the issues

Sleep

Volumn 23, Issue SUPPL. 1, 2000, Pages

  Richardson, Gary S ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE UTILIZATION; HUMAN; INSOMNIA; MEDICAL SPECIALIST; PATIENT SATISFACTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER;

ADULT; HUMANS; PRIMARY HEALTH CARE; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 0034143820     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997; 154:1417-1423.
2. Shochat T, Umphress J, Israel AG, Ancoli-Israel S. Insomnia in primary care patients. Sleep 1999;22(suppl 2):S359-S365.
3. Hohagen F, Kappler C, Schramm E, et al. Prevalence of insomnia in elderly general practice attenders and the current treatment modalities. Acta Psychiatr Scand 1994;90:102-108.
4. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. JAMA 1989;262:1479-1484.
5. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep 1999;22(suppl 2):S379-S385.
6. Walsh JK, Muehlbach MJ, Lauter SA, Hilliker NA, Schweitzer PK. Effects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis. J Rheumatol 1996;23:245-252.
7. Roth T, Ancoli-Israel S, Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. Sleep 1999;22(suppl 2):S354-S358.
8. National Sleep Foundation/Gallup Organization. Sleep in America: 1995. Princeton, NJ: Gallup Organization, 1995.
9. Elie R, Rüther E, Farr I, et al. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. J Clin Psychiatry 1999;60:536-544.
10. Spielman AJ, Nunes, J, Glovinsky PB. Insomnia. Neurol Clin 1996;14:513-543.
11. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia. JAMA 1999;281:991-999.
12. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. N Engl J Med 1996;335:1001-1009.